24.32
4.11%
0.96
전일 마감가:
$23.36
열려 있는:
$24
하루 거래량:
104.81K
Relative Volume:
0.36
시가총액:
$158.45M
수익:
-
순이익/손실:
$-156.09M
주가수익비율:
-17.13
EPS:
-1.42
순현금흐름:
$-102.69M
1주 성능:
-17.39%
1개월 성능:
-30.32%
6개월 성능:
+117.66%
1년 성능:
+6,545%
인스틸 바이오 Stock (TIL) Company Profile
명칭
Instil Bio Inc
전화
(972) 499-3350
주소
3963 MAPLE AVENUE, DALLAS
TIL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
TIL | 24.19 | 158.45M | 0 | -156.09M | -102.69M | -1.42 |
VRTX | 449.69 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 748.75 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 588.46 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 247.89 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
인스틸 바이오 Stock (TIL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-11-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
2022-11-01 | 다운그레이드 | Truist | Buy → Hold |
2021-08-13 | 개시 | Robert W. Baird | Outperform |
2021-04-13 | 개시 | Cowen | Outperform |
2021-04-13 | 개시 | Morgan Stanley | Equal-Weight |
2021-04-13 | 개시 | Truist | Buy |
모두보기
인스틸 바이오 주식(TIL)의 최신 뉴스
(TIL) Trading Report - Stock Traders Daily
Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
Instil Bio Secures Global Rights to PD-L1xVEGF Drug, Reports $122.9M Cash Position | TIL Stock News - StockTitan
2 Stocks Up Over 700% in 2024 That Could Soar Even Further - AOL
(TIL) Technical Data - Stock Traders Daily
JMP Securities initiates Instil Bio shares at Market Perform on public offering - Investing.com Australia
Instil Bio, Inc.'s (NASDAQ:TIL) stock price dropped 18% last week; private equity firms would not be happy - Simply Wall St
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? - The Motley Fool
Analysis of Curative Ventures V LLC's Strategic Reduction in Instil Bio Inc - GuruFocus.com
(TIL) Long Term Investment Analysis - Stock Traders Daily
Baird maintains price target on Instil Bio stock, stays upbeat - Investing.com
5 Top NASDAQ Biotech Stocks of 2024 - Nasdaq
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% - Baystreet.ca
Instil Bio Stock Skyrockets 641% in One Week: Here's Why - MSN
BOXER CAPITAL, LLC Acquires New Stake in Instil Bio Inc - GuruFocus.com
Perceptive Advisors LLC Acquires New Stake in Instil Bio Inc - GuruFocus.com
Baird sees Instil Bio stock upside on promising SYN-2510 clinical data - Investing.com
Fantastic Fest 2024: Clowns Rule at Texas’ No-Joke Genre Event Set to Debut ‘Terrifier 3,’ ‘V/H/S Beyond,’ and More - IndieWire
B. Riley Analysts Decrease Earnings Estimates for Inspired Entertainment, Inc. (NASDAQ:INSE) - Defense World
The time has not yet come to remove your chips from the table: Instil Bio Inc (TIL) - SETE News
Financial Metrics Unveiled: Instil Bio Inc (TIL)’s Key Ratios in the Spotlight - The Dwinnex
Instil Bio (TIL) Stock Rises In Extended Session On Major Strategy Reveal - Stocks Telegraph
Inspired Entertainment, Inc. to Post Q3 2024 Earnings of $0.22 Per Share, B. Riley Forecasts (NASDAQ:INSE) - Defense World
Ice Nine Kills to Release Official Song for Slasher Film Terrifier 3 - MetalSucks
Baird retains price target, outperform rating on Instil Bio shares By Investing.com - Investing.com Australia
Ice Nine Kills are releasing a new single for Terrifier 3 - Kerrang!
Ice Nine Kills’ Upcoming Single “A Work of Art” to Feature on "Terrifier 3" Soundtrack - Ghost Cult Magazine
Here's Why Everyone's Talking About Summit Therapeutics - MSN
This is why everyone is talking about Summit TherapeuticsTHE BHARAT EXPRESS NEWS - The Bharat Express News
Instil Bio stock target raised by H.C. Wainwright on cancer drug outlook - Investing.com
instilbiocorppres2024091.htm - SEC.gov
ICE NINE KILLS announce new 'TERRIFIER'-themed single and video starring SHAVO ODADJIAN - Revolver Magazine
Official 'Terrifier 3' Music Video from Ice Nine Kills Slashing into Fantastic Fest & AMC Theatres! - Bloody Disgusting
Crude Oil Surges Over 1%; Instil Bio Shares Plunge - MSN
Baird retains price target, outperform rating on Instil Bio shares - Investing.com India
Instil Bio Inc (TIL) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Baird positive on Instil Bio’s SYN-2510 development strategy - TipRanks
Do investors need to be concerned about Instil Bio Inc (TIL)? - US Post News
Instil Bio Outlines Oncology Strategy and Collaborative Efforts - TipRanks
Instil Bio price target raised to $120 from $40 at H.C. Wainwright - TipRanks
Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer - Yahoo Finance
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - sharewise
Baird ups Instil Bio shares target as PD-1/L1xVEGF space gains momentum - Investing.com India
Summit lifts Instil, BioNTech on Merck beating data (NASDAQ:SMMT) - Seeking Alpha
Instil Bio: PD-L1/VEGF Bispecific Targeting With Unique Enhancements (TIL) - Seeking Alpha
Instil Bio surges after Baird target calls for shares tripling - TipRanks
(TIL) On The My Stocks Page - Stock Traders Daily
Instil Bio’s Stock Price Target (NASDAQ: TIL) Get’s A Big Uplift From Baird - AskTraders
H.C. Wainwright raises Instil Bio shares target with Buy rating By Investing.com - Investing.com Australia
Instil Bio price target raised to $180 from $32 at Baird - TipRanks
인스틸 바이오 (TIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):